Table 1.

Summary information about treatment and treatment delivery system

	Cryotherapy*		LEEP*
	n	(%)	n	(%)
Indications/contraindications**
Restrictions based on lesion size and extension	8	(72.7)	0	(0.0)
Transformation zone entirely visible	6	(54.5)	2	(12.5)
No evidence of invasive disease	6	(54.5)	5	(31.3)
No history of screening or treatment for CIN	7	(63.6)	2	(12.5)
No gynecologic abnormality†	4	(36.4)	1	(6.3)
No severe cervicitis	1	(9.1)	2	(12.5)
Restrictions for pregnant women††	6	(54.5)	3	(18.8)
Contraindication to cryotherapy	0	(0.0)	5	(31.3)
Enrollment**
Community outreach	7	(63.6)	4	(25.0)
Primary care/local health centers	3	(27.3)	1	(6.3)
Gynecologic clinic/tertiary care	3	(27.3)	10	(62.5)
Not reported	0	(0.0)	1	(6.3)
Type of treatment center**
Gynecologic clinic/tertiary care	4	(36.4)	12	(75.0)
District hospital	2	(18.2)	2	(12.5)
Primary care center/mobile unit	8	(72.7)	1	(6.3)
Not reported	1	(9.1)	1	(6.3)
Number of treatment centers
One	5	(45.5)	16	(100)
Two or more	5	(45.5)	0	(0)
Not reported	1	(9.1)	0	(0)
Operator
Gynecologist, surgeon	1	(9.1)	4	(25.0)
Doctor, general practitioner	2	(18.2)	4	(25.0)
Nurse, "less qualified personnel"	5	(45.5)	1	(6.3)
Not reported	3	(27.3)	7	(43.8)
Number of operators
One	1	(9.1)	1	(6.3)
Two to five	1	(9.1)	5	(31.3)
Six or more	5	(45.5)	0	(0)
Not reported	4	(36.4)	10	(62.5)
Control of pain
No specific measure/Non-narcotic analgesics as needed	5	(45.5)	0	(0.0)
Local anesthesia	0	(0.0)	12	(75.0)
General anesthesia	0	(0.0)	1	(6.3)
Not reported	6	(54.5)	3	(18.8)
Antibiotherapy (pre-treatment)
Signs of cervicitis or STD	3	(27.3)	2	(12.5)
All women	4	(36.4)	3	(18.8)
Not reported	4	(36.4)	11	(68.8)

*Cryotherapy, 11 studies; LEEP, 16 studies.

**Total percent add to more than 100%, because some studies are represented in more than one item category.

^†Abnormalities such as polyp or cervical atrophy, for instance.

^††Different gestational ages across studies.